BALPHARMA.BOBALPHARMA.BOBSE
Loading
Net Margin Over TimeExpanding
Percentile Rank80
3Y CAGR+45.9%
5Y CAGR+6.5%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
+45.9%/yr
vs -15.8%/yr prior
5Y CAGR
+6.5%/yr
Recent acceleration
Acceleration
+61.7pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM2.63%+10.3%
20252.38%+9.2%
20242.18%+157.8%
20230.85%-57.6%
20222.00%+3.9%
20211.92%+126.9%
2020-7.14%-524.2%
20191.68%+26.6%
20181.33%+53.2%
20170.87%-